These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 24025102)

  • 21. In vitro and in vivo comparison of 18F and 123I-labeled ML10 with 68Ga-Cys2-AnxA5 for molecular imaging of apoptosis.
    Bauwens M; De Saint-Hubert M; Cleynhens J; Vandeputte C; Li J; Devos E
    Q J Nucl Med Mol Imaging; 2013 Jun; 57(2):187-200. PubMed ID: 23389693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiparameter noninvasive assessment of treatment susceptibility, drug target inhibition and tumor response guides cancer treatment.
    Gee MS; Upadhyay R; Bergquist H; Weissleder R; Josephson L; Mahmood U
    Int J Cancer; 2007 Dec; 121(11):2492-500. PubMed ID: 17683072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Aiming for zero blindness].
    Nakazawa T
    Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preclinical in vivo cancer, straightway to patients?
    de Jong M; Mather S; Maina T
    Q J Nucl Med Mol Imaging; 2017 Jun; 61(2):145-152. PubMed ID: 28347131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. XTEN-annexin A5: XTEN allows complete expression of long-circulating protein-based imaging probes as recombinant alternative to PEGylation.
    Haeckel A; Appler F; Figge L; Kratz H; Lukas M; Michel R; Schnorr J; Zille M; Hamm B; Schellenberger E
    J Nucl Med; 2014 Mar; 55(3):508-14. PubMed ID: 24549285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positron emission tomography-adapted therapy for first-line treatment in individuals with Hodgkin lymphoma.
    Sickinger MT; von Tresckow B; Kobe C; Engert A; Borchmann P; Skoetz N
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010533. PubMed ID: 25572491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. (18)F-FDG-PET/CT in evaluating response to therapy in solid tumors: where we are and where we can go.
    Herrmann K; Benz MR; Krause BJ; Pomykala KL; Buck AK; Czernin J
    Q J Nucl Med Mol Imaging; 2011 Dec; 55(6):620-32. PubMed ID: 22231582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of near-infrared dyes for tumor imaging, photothermal, and photodynamic therapies.
    Yuan A; Wu J; Tang X; Zhao L; Xu F; Hu Y
    J Pharm Sci; 2013 Jan; 102(1):6-28. PubMed ID: 23132644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advantages of the phosphatidylserine-recognizing peptide PSP1 for molecular imaging of tumor apoptosis compared with annexin V.
    Kim S; Bae SM; Seo J; Cha K; Piao M; Kim SJ; Son HN; Park RW; Lee BH; Kim IS
    PLoS One; 2015; 10(3):e0121171. PubMed ID: 25803297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular imaging of atherosclerotic lesions by positron emission tomography - can it meet the expectations?
    Brammen L; Steiner S; Berent R; Sinzinger H
    Vasa; 2016; 45(2):125-32. PubMed ID: 27058798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Broad and specific caspase inhibitor-induced acute repression of apoptosis in atherosclerotic lesions evaluated by radiolabeled annexin A5 imaging.
    Sarai M; Hartung D; Petrov A; Zhou J; Narula N; Hofstra L; Kolodgie F; Isobe S; Fujimoto S; Vanderheyden JL; Virmani R; Reutelingsperger C; Wong ND; Gupta S; Narula J
    J Am Coll Cardiol; 2007 Dec; 50(24):2305-12. PubMed ID: 18068039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular imaging of cell death.
    De Saint-Hubert M; Prinsen K; Mortelmans L; Verbruggen A; Mottaghy FM
    Methods; 2009 Jun; 48(2):178-87. PubMed ID: 19362149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular Probes for Imaging the Sigma-2 Receptor: In Vitro and In Vivo Imaging Studies.
    Zeng C; McDonald ES; Mach RH
    Handb Exp Pharmacol; 2017; 244():309-330. PubMed ID: 28176045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiolabeled Nanoparticles for Cancer Diagnosis and Therapy.
    Koziorowski J; Stanciu AE; Gomez-Vallejo V; Llop J
    Anticancer Agents Med Chem; 2017; 17(3):333-354. PubMed ID: 26899184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular imaging of apoptosis: from micro to macro.
    Zeng W; Wang X; Xu P; Liu G; Eden HS; Chen X
    Theranostics; 2015; 5(6):559-82. PubMed ID: 25825597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apoptosis imaging studies in various animal models using radio-iodinated peptide.
    Kwak W; Ha YS; Soni N; Lee W; Park SI; Ahn H; An GI; Kim IS; Lee BH; Yoo J
    Apoptosis; 2015 Jan; 20(1):110-21. PubMed ID: 25430587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sigma Receptor (σR) Ligands with Antiproliferative and Anticancer Activity.
    Georgiadis MO; Karoutzou O; Foscolos AS; Papanastasiou I
    Molecules; 2017 Aug; 22(9):. PubMed ID: 28841173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PET imaging of apoptosis with (64)Cu-labeled streptavidin following pretargeting of phosphatidylserine with biotinylated annexin-V.
    Cauchon N; Langlois R; Rousseau JA; Tessier G; Cadorette J; Lecomte R; Hunting DJ; Pavan RA; Zeisler SK; van Lier JE
    Eur J Nucl Med Mol Imaging; 2007 Feb; 34(2):247-58. PubMed ID: 17021816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New PET radiopharmaceuticals beyond FDG for brain tumor imaging.
    Gulyás B; Halldin C
    Q J Nucl Med Mol Imaging; 2012 Apr; 56(2):173-90. PubMed ID: 22617239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting Programmed Cell Death Using Small-Molecule Compounds to Improve Potential Cancer Therapy.
    Ke B; Tian M; Li J; Liu B; He G
    Med Res Rev; 2016 Nov; 36(6):983-1035. PubMed ID: 27357603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.